Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cadrenal Therapeutics, Inc. (CVKD) had Operating Cash Flow per Share of $-3.91 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.67M |
|
-- |
|
-- |
|
$3.73M |
|
$-3.73M |
|
$0.07M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.67M |
|
$-3.73M |
|
$-3.73M |
|
1.96M |
|
1.96M |
|
$-1.87 |
|
$-1.87 |
|
| Balance Sheet Financials | |
$5.97M |
|
$0.00M |
|
$0.01M |
|
$5.98M |
|
$1.68M |
|
-- |
|
-- |
|
$1.68M |
|
$4.30M |
|
$4.30M |
|
$4.30M |
|
2.01M |
|
| Cash Flow Statement Financials | |
$-7.67M |
|
$-0.00M |
|
$3.23M |
|
$10.02M |
|
$5.57M |
|
$-4.45M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-85.31% |
|
-85.31% |
|
-61.34% |
|
-85.31% |
|
$2.14 |
|
$-3.91 |
|
|
Operating Cash Flow per Share |
$-3.91 |